KRT18 and metabolic dysfunction-associated steatotic liver disease: A previous study [7] conducted by Wieckowska et al. showed that cytokeratin 18 (CK18) is at high levels and positively correlated with liver fibrosis stage in patients with non-alcoholic fatty liver disease (NAFLD).